Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiden

Showing results (441-450 of 978) with videos related to

Pageof 98
Sort By:
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 3, 2025
A proof-of-concept study of pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndromeAmee Revana, Rakesh Bhattacharjee, Jennifer L Miller, et al.
JCO Precision Oncology|July 19, 2023
Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for CancersAlan H Bryce, David D Thiel, Michael V Seiden, et al.
Sleep|August 6, 2021
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsyClete A Kushida, Colin M Shapiro, Thomas Roth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancerP A Vasey, L N Shulman, S Campos, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 14, 2002
Gender discrimination and sexual harassment in medical education: perspectives gained by a 14-school studyLois Margaret Nora, Margaret A McLaughlin, Sue E Fosson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumorsMichael V Seiden, Shu-Wing Ng, Jeffrey G Supko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignanciesD P Ryan, J G Supko, J P Eder, et al.
Oncogene|July 13, 2004
Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasisJiang Liu, Fiona Blackhall, Isolde Seiden-Long, et al.
CJEM|September 29, 2018
Sex-specific, high-sensitivity cardiac troponin T cut-off concentrations for ruling out acute myocardial infarction with a single measurementAndrew McRae, Michelle Graham, Tasnima Abedin, et al.
Cancer|September 26, 2001
A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumorsR T Penson, J G Supko, M V Seiden, et al.
Pageof 98

Showing results (441-450 of 978) with videos related to

Sort By:
Pageof 98
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 3, 2025
A proof-of-concept study of pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndromeAmee Revana, Rakesh Bhattacharjee, Jennifer L Miller, et al.
JCO Precision Oncology|July 19, 2023
Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for CancersAlan H Bryce, David D Thiel, Michael V Seiden, et al.
Sleep|August 6, 2021
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsyClete A Kushida, Colin M Shapiro, Thomas Roth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancerP A Vasey, L N Shulman, S Campos, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|December 14, 2002
Gender discrimination and sexual harassment in medical education: perspectives gained by a 14-school studyLois Margaret Nora, Margaret A McLaughlin, Sue E Fosson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumorsMichael V Seiden, Shu-Wing Ng, Jeffrey G Supko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignanciesD P Ryan, J G Supko, J P Eder, et al.
Oncogene|July 13, 2004
Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasisJiang Liu, Fiona Blackhall, Isolde Seiden-Long, et al.
CJEM|September 29, 2018
Sex-specific, high-sensitivity cardiac troponin T cut-off concentrations for ruling out acute myocardial infarction with a single measurementAndrew McRae, Michelle Graham, Tasnima Abedin, et al.
Cancer|September 26, 2001
A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumorsR T Penson, J G Supko, M V Seiden, et al.
Pageof 98